Satellos prices $50M public offering
Source: SeekingAlpha
2026-02-06 09:00:17 ET
More on Satellos Bioscience Inc.
- Satellos launches public offering, applies for Nasdaq listing
- Seeking Alpha’s Quant Rating on Satellos Bioscience Inc.
- Historical earnings data for Satellos Bioscience Inc.
- Financial information for Satellos Bioscience Inc.
Read the full article on Seeking Alpha
For further details see:
Satellos prices $50M public offering
Satellos Bioscience Inc.
NASDAQ: MSCL:CC
MSCL:CC Trading
-2.11% G/L:
$0.93 Last:
50,284 Volume:
$0.93 Open:
MSCL:CC Latest News
March 10, 2026 07:00:00 am
Satellos Presents Interim SAT-3247 Clinical and Biomarker Data in Duchenne Muscular Dystrophy at the 2026 MDA Clinical & Scientific Conference
February 24, 2026 07:00:00 am
Satellos Announces Upcoming Oral and Poster Presentations at the 2026 Muscular Dystrophy Association Clinical & Scientific Conference
February 18, 2026 07:00:00 am
Satellos to Host Virtual KOL Event on SAT-3247 in Duchenne Muscular Dystrophy
